Canadá - inglés - Health Canada

sterimax inc - baclofen - solution - 10mg - baclofen 10mg - gaba-derivative skeletal muscle relaxants

Bélgica - inglés - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

novartis pharma sa-nv - baclofen 10 mg - tablet - 10 mg - baclofen 10 mg - baclofen

Estados Unidos - inglés - NLM (National Library of Medicine)

unit dose services - baclofen (unii: h789n3fke8) (baclofen - unii:h789n3fke8) - baclofen 20 mg - baclofen tablets usp are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. patients should have reversible spasticity so that baclofen treatment will aid in restoring residual function. baclofen tablets usp may also be of some value in patients with spinal cord injuries and other spinal cord diseases. baclofen tablets usp are not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. the efficacy of baclofen in stroke, cerebral palsy, and parkinson’s disease has not been established and, therefore, it is not recommended for these conditions. hypersensitivity to baclofen.

Singapur - inglés - HSA (Health Sciences Authority)

medicell pharmaceutical (s) pte. ltd. - baclofen - tablet - 10 mg - baclofen 10 mg

Canadá - inglés - Health Canada

teva canada limited - baclofen - tablet - 20mg - baclofen 20mg - gaba-derivative skeletal muscle relaxants

Canadá - inglés - Health Canada

laboratoire riva inc. - baclofen - tablet - 20mg - baclofen 20mg - gaba-derivative skeletal muscle relaxants

Australia - inglés - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - baclofen, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - lioresal intrathecal is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

aguettant ltd - baclofen - solution for infusion - 2mg/1ml

Australia - inglés - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - baclofen, quantity: 500 microgram/ml - injection, solution - excipient ingredients: water for injections; sodium chloride - lioresal intrathecal is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

aguettant ltd - baclofen - solution for infusion - 500microgram/1ml